411 related articles for article (PubMed ID: 11465075)
1. Membrane transporters and antifungal drug resistance.
St Georgiev V
Curr Drug Targets; 2000 Nov; 1(3):261-84. PubMed ID: 11465075
[TBL] [Abstract][Full Text] [Related]
2. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
3. Vacuolar Sequestration of Azoles, a Novel Strategy of Azole Antifungal Resistance Conserved across Pathogenic and Nonpathogenic Yeast.
Khandelwal NK; Wasi M; Nair R; Gupta M; Kumar M; Mondal AK; Gaur NA; Prasad R
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642932
[TBL] [Abstract][Full Text] [Related]
4. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the multi-drug efflux systems of pathogenic fungi using functional hyperexpression in Saccharomyces cerevisiae.
Niimi M
Nihon Ishinkin Gakkai Zasshi; 2010; 51(2):79-86. PubMed ID: 20467195
[TBL] [Abstract][Full Text] [Related]
6. All about CDR transporters: Past, present, and future.
Prasad R; Balzi E; Banerjee A; Khandelwal NK
Yeast; 2019 Apr; 36(4):223-233. PubMed ID: 30192990
[TBL] [Abstract][Full Text] [Related]
7. An actin depolymerizing agent 19,20-epoxycytochalasin Q of Xylaria sp. BCC 1067 enhanced antifungal action of azole drugs through ROS-mediated cell death in yeast.
Somboon P; Soontorngun N
Microbiol Res; 2021 Feb; 243():126646. PubMed ID: 33227681
[TBL] [Abstract][Full Text] [Related]
8. Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3.
Monod M; Feuermann M; Salamin K; Fratti M; Makino M; Alshahni MM; Makimura K; Yamada T
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501141
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review.
Mishra NN; Prasad T; Sharma N; Payasi A; Prasad R; Gupta DK; Singh R
Acta Microbiol Immunol Hung; 2007 Sep; 54(3):201-35. PubMed ID: 17896473
[TBL] [Abstract][Full Text] [Related]
10. Medically important fungi respond to azole drugs: an update.
Zavrel M; White TC
Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
[TBL] [Abstract][Full Text] [Related]
11. Efflux pumps in drug resistance of Candida.
Prasad R; Gaur NA; Gaur M; Komath SS
Infect Disord Drug Targets; 2006 Jun; 6(2):69-83. PubMed ID: 16789872
[TBL] [Abstract][Full Text] [Related]
12. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
13. Two natural molecules preferentially inhibit azole-resistant Candida albicans with MDR1 hyperactivation.
Shi HZ; Chang WQ; Zhang M; Lou HX
Chin J Nat Med; 2019 Mar; 17(3):209-217. PubMed ID: 30910057
[TBL] [Abstract][Full Text] [Related]
14. Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
Nishimoto AT; Sharma C; Rogers PD
J Antimicrob Chemother; 2020 Feb; 75(2):257-270. PubMed ID: 31603213
[TBL] [Abstract][Full Text] [Related]
15. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
16. A State-of-the-art Review and Prospective Therapeutic Applications of Prenyl Flavonoids as Chemosensitizers against Antifungal Multidrug Resistance in Candida albicans.
Santi MD; Ortega MG; Peralta MA
Curr Med Chem; 2022; 29(24):4251-4281. PubMed ID: 35139777
[TBL] [Abstract][Full Text] [Related]
17. [Pleiotropic drug resistance ABC transporters in fungi].
Wang Q; Cui ZF
Yi Chuan; 2011 Oct; 33(10):1048-56. PubMed ID: 21993279
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
19. Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast.
Yamawaki C; Oyama M; Yamaguchi Y; Ogita A; Tanaka T; Fujita KI
Lett Appl Microbiol; 2019 Jan; 68(1):17-23. PubMed ID: 30276838
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the antifungal activity of new medicinal plant extracts active on Candida glabrata by the major transporters and regulators of the pleiotropic drug-resistance network in Saccharomyces cerevisiae.
Kolaczkowski M; Kolaczkowska A; Stermitz FR
Microb Drug Resist; 2009 Mar; 15(1):11-7. PubMed ID: 19216644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
